The Northwestern Alzheimer's Disease Core Center (ADCC) was established in 1996 and is currently in the final year of its second 5-year cycle. Three principal goals guide the activities of the Center: 1) The facilitation of research on the neurobiology, early diagnosis, temporal course, neuropsychology, risk factors, prevention, and therapy of dementias. 2) The establishment of collaborative interactions with other ADCs and local AD-related activities. 3) The transfer of relevant research benefits to patients, families and underserved populations. ? ? In order to serve these goals during the past 5 years covered by this progress report, our Clinical Core evaluated 1705 patients and their cognitively intact controls and maintains an active cohort of nearly 600 subjects while our Neuropathology Core acquired 194 brains and 646 DNA specimens and maintains a total inventory of 331 brains and 1186 DNA samples; 34 research projects used our tissue resources and 48 projects used our patient resources; the availability of these resources contributed to 141 publications; we reviewed 29 and awarded 10 pilot grants which allowed the awardees to receive over $6M of funding; our yearly Alzheimer Day scientific sessions attracted 195 posters describing work at Northwestern University; our outreach work in underserved minority communities earned the praise of the Illinois Department of Public Health, the Chicago Department on Aging, the Mexican Consulate of Chicago and the Alzheimer's Association; our prize-winning website received nearly 45,000 visits per month; we are a designated Illinois State AD center, participated in ADCS, ADNI, LOAD and NCRAD; and received a NACC grant to lead a multi-ADC consortium on FTD. Fifty-one faculty members at Northwestern University are affiliated with the ADCC. Their funding for dementia-related research this current year is over $12M. During the last 5 years, research in this field has attracted nearly $50M of new direct funding to Northwestern University and has enabled the publication of over 250 papers, chapters and abstracts, some of which have received widespread media attention. ? ? The ADCC has played an active role in integrating these dementia-related clinical, research and outreach activities into a coherent whole and in providing the infrastructure for making them thrive. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013854-13
Application #
7459626
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (M1))
Program Officer
Phelps, Creighton H
Project Start
1997-07-15
Project End
2011-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
13
Fiscal Year
2008
Total Cost
$1,103,208
Indirect Cost
Name
Northwestern University at Chicago
Department
Neurology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Ohm, D T; Kim, G; Gefen, T et al. (2018) Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia. Neuropathol Appl Neurobiol :
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Tirrell, Timothy F; Rademaker, Alfred W; Lieber, Richard L (2018) Analysis of hierarchical biomechanical data structures using mixed-effects models. J Biomech 69:34-39
Gefen, Tamar; Ahmadian, Saman S; Mao, Qinwen et al. (2018) Combined Pathologies in FTLD-TDP Types A and C. J Neuropathol Exp Neurol 77:405-412
Raghanti, Mary Ann; Edler, Melissa K; Stephenson, Alexa R et al. (2018) A neurochemical hypothesis for the origin of hominids. Proc Natl Acad Sci U S A 115:E1108-E1116
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679

Showing the most recent 10 out of 443 publications